Health Econ On The Go

Welcome to the fifth episode of Health Econ On The Go. In this episode, we will cover three papers from April 2024, touching on the impact of willingness-to-pay thresholds on access to cancer drugs, a review of the pay-for-performance scheme in Brazil and an analysis of the relationship between welfare generosity and health. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.comPapers discussed on this episode: "The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health", available here: https://becarispublishing.com/doi/full/10.57264/cer-2023-0178"Does pay-for-performance design matter? Evidence from Brazil" available here: https://pubmed.ncbi.nlm.nih.gov/38661300/#:~:text=The%20cluster%20analysis%20showed%20what,in%20the%20mean%20PMAQ%20score."Is Redistribution Good for Our Health? Examining the Macro-Correlation between Welfare Generosity and Health across EU Nations over the Last 40 Years" available here: https://pubmed.ncbi.nlm.nih.gov/38567772/The suggested movie is "Dark Waters" (https://www.imdb.com/title/tt9071322/)

Welcome to the fourth episode of Health Econ On The Go. In this episode, we will cover three papers from March 2024, discussing financial incentives for integrated care, wellbeing improvements as a novel outcome measure in health, and the rising costs of oncology drugs in Canada. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.com Papers discussed on this episode: “A QALY is [still] a QALY is [still] a QALY?” available here: https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-024-01036-w “Financial incentives for integrated care: A scoping review and lessons for evidence-based design” available here: https://pubmed.ncbi.nlm.nih.gov/38290390/ “From Health to Wellbeing: Toward a Monetary Valuation of a Wellbeing-Adjusted Life-Year“ available here: https://www.valueinhealthjournal.com/article/S1098-3015(24)00087-1/fulltext” “Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study“ available here: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00072-X/abstract Sedated: How Modern Capitalism Created our Mental Health Crisis – Book review available here: https://www.goodreads.com/en/book/show/57751566

Welcome to the third episode of Health Econ On The Go. In this episode, we will cover three papers from February 2024, touching on the cost-effectiveness of an early parenting programme, the cost-effectiveness of malaria vaccination and a review of the impact of economic policies on hypertension management. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.com Papers discussed on this episode:  "Why are our medicines so expensive? Spoiler: Not for the reasons you are being told…" available here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10836477/ "A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme" available here: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-10492-w "The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study " available here: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00816-2/fulltext "Association of Economic Policies With Hypertension Management and ControlA Systematic Review" available here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2814987 "El susto" available here: https://elsustomovie.com/

Welcome to the second episode of Health Econ On The Go. In this episode, we will cover three papers from January 2024, touching on the impact of taxes on the consumption of sugary beverages, types of epidemiological and macroeconomic models and a review of payment reform in the inpatient sector. We launched this podcast with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.com Papers discussed on this episode:   ⁠“Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies" available here: https://www.sciencedirect.com/science/article/pii/S0168851023002750 “Evaluation of changes in price and purchases following implementation of sugar-sweetened beverage taxes across the US" available here: https://jamanetwork.com/journals/jama-health-forum/fullarticle/2813506 ⁠“A scoping review and taxonomy of epidemiological-macroeconomic models of COVID-19" available here: https://www.valueinhealthjournal.com/article/S1098-3015(23)06154-5/fulltext ⁠“The end of an era? Activity-based funding based on diagnostic-related groups: a review of payment reforms in the inpatient sector in 10 high-income countries" available here: https://www.sciencedirect.com/science/article/pii/S0168851023002750

Welcome to the first episode of Health Econ On The Go. In this episode, we will cover the top 10 trends for 2024-2025 by ISPOR and two papers from December 2023. The first paper will discuss financing health and care workers in 33 African countries, and the second will discuss a framework for the fair pricing of medicine. I am launching with the moto "finish not perfect", so please leave me your comments and questions at healthecononthego@gmail.com